Review article · 2024 · Open access

Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes

Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, Alexis R. Smith, Harashkumar Vasanthakumari Thirumalaiswamy, Hariprasath Kandhasamy, Boutheina Zender, Guangrong Zheng, Loganathan Rangasamy

Pharmacology & Therapeutics, 263, 108725 · Published 23 September 2024 · DOI 10.1016/j.pharmthera.2024.108725

Open full textView at the publisherCite this paper

In brief

“Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes” is a 2024 review article by Janarthanan Venkatesan and 8 co-authors, published in Pharmacology & Therapeutics. OpenAlex counts 50 citations as of 21 November 2026. It is open access: the full text is free to read at SSRN Electronic Journal.

Citations
50
Most cited in
2026 (34)
Field-weighted impact
1.63
References
136
Authors
9

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Venkatesan, J., Murugan, D., Lakshminarayanan, K., Smith, A. R., Thirumalaiswamy, H. V., Kandhasamy, H., Zender, B., Zheng, G., & Rangasamy, L. (2024). Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes. Pharmacology & Therapeutics, 263, 108725. https://doi.org/10.1016/j.pharmthera.2024.108725

MLA 9

Venkatesan, Janarthanan, et al. “Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes.” Pharmacology & Therapeutics, vol. 263, 2024, p. 108725. https://doi.org/10.1016/j.pharmthera.2024.108725.

Chicago

Venkatesan, Janarthanan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, Alexis R. Smith, Harashkumar Vasanthakumari Thirumalaiswamy, Hariprasath Kandhasamy, Boutheina Zender, Guangrong Zheng, and Loganathan Rangasamy. 2024. “Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes.” Pharmacology & Therapeutics 263: 108725. https://doi.org/10.1016/j.pharmthera.2024.108725.

Harvard

Venkatesan, J. et al. (2024) ‘Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes’, Pharmacology & Therapeutics, 263, p. 108725. doi:10.1016/j.pharmthera.2024.108725.

IEEE

J. Venkatesan et al., “Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes,” Pharmacology & Therapeutics, vol. 263, p. 108725, 2024, doi: 10.1016/j.pharmthera.2024.108725.

BibTeX

@article{venkatesan2024powering,
  title     = {{Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes}},
  author    = {Venkatesan, Janarthanan and Murugan, Dhanashree and Lakshminarayanan, Kalaiarasu and Smith, Alexis R. and Thirumalaiswamy, Harashkumar Vasanthakumari and Kandhasamy, Hariprasath and Zender, Boutheina and Zheng, Guangrong and Rangasamy, Loganathan},
  journal   = {Pharmacology \& Therapeutics},
  year      = {2024},
  volume    = {263},
  pages     = {108725},
  doi       = {10.1016/j.pharmthera.2024.108725},
  url       = {https://doi.org/10.1016/j.pharmthera.2024.108725}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
20251515
20263434

Its field-weighted citation impact is 1.63: it has been cited 1.63 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • targeted protein degradation
  • PROTACs
  • lysosome-targeting chimeras
  • molecular glues
  • antibody conjugates
  • cancer therapeutics
  • drug delivery challenges

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Venkatesan, J., Murugan, D., Lakshminarayanan, K., Smith, A. R., Thirumalaiswamy, H. V., Kandhasamy, H., Zender, B., Zheng, G., & Rangasamy, L. (2024). Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes. Pharmacology & Therapeutics, 263, 108725. https://doi.org/10.1016/j.pharmthera.2024.108725

How many times has this paper been cited?

50 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at SSRN Electronic Journal: sign in and open the full text from this page.

Who wrote this paper?

Janarthanan Venkatesan, Dhanashree Murugan, Kalaiarasu Lakshminarayanan, Alexis R. Smith, Harashkumar Vasanthakumari Thirumalaiswamy, Hariprasath Kandhasamy, Boutheina Zender, Guangrong Zheng, Loganathan Rangasamy.

What is the DOI of this paper?

10.1016/j.pharmthera.2024.108725, permanently at https://doi.org/10.1016/j.pharmthera.2024.108725. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.